We are live on ! Find out more
RYZB

RayzeBio, Inc. Common Stock
RYZB

Delisted

RYZB was delisted on the 23rd of February, 2024.

Back to rankings

68 hedge funds and large institutions have $1.2B invested in RayzeBio, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 68 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+68
Holders Change %
–
% of All Funds
1.08%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
% of All Funds
0.13%
New
68
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$139M
2
VP
venBio Partners
California
+$108M
3
VVM
Versant Venture Management
California
+$108M
4
VA
VR Adviser
New York
+$84.3M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$81.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$147M +$139M +6,642,700 New
VP
2
venBio Partners
California
$115M +$108M +5,158,162 New
VVM
3
Versant Venture Management
California
$115M +$108M +5,158,161 New
VA
4
VR Adviser
New York
$89.2M +$84.3M +4,016,847 New
Wellington Management Group
5
Wellington Management Group
Massachusetts
$84.5M +$81.4M +3,876,186 New
O
6
OrbiMed
New York
$58.2M +$55.1M +2,622,909 New
SI
7
Sofinnova Investments
California
$53.7M +$50.8M +2,419,528 New
RG
8
Redmile Group
California
$41.2M +$39M +1,857,706 New
SB
9
Samsara BioCapital
California
$41M +$38.8M +1,845,948 New
HA
10
HHLR Advisors
Cayman Islands
$31M +$29.3M +1,395,716 New
Capital Research Global Investors
11
Capital Research Global Investors
California
$27.8M +$26.2M +1,250,000 New
AllianceBernstein
12
AllianceBernstein
Tennessee
$27.4M +$25.9M +1,234,636 New
FFM
13
Fairmount Funds Management
Pennsylvania
$27.1M +$25.7M +1,221,904 New
SCV
14
Sands Capital Ventures
Virginia
$26.5M +$25.1M +1,195,589 New
CAM
15
Cormorant Asset Management
Massachusetts
$26.2M +$24.8M +1,182,263 New
DM
16
Deerfield Management
New York
$25.7M +$24.3M +1,159,126 New
Fidelity Investments
17
Fidelity Investments
Massachusetts
$25.3M +$23.9M +1,138,972 New
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$22.9M +$21.7M +1,033,578 New
LCM
19
Laurion Capital Management
New York
$21.6M +$20.4M +971,913 New
TCM
20
TCG Crossover Management
California
$19.3M +$18.3M +869,908 New
Franklin Resources
21
Franklin Resources
California
$18.5M +$17.5M +833,333 New
AWGLSCP
22
ABG-WTT Global Life Science Capital Partners
Hong Kong
$17.3M +$16.4M +778,922 New
PA
23
Perceptive Advisors
New York
$17.2M +$16.3M +776,805 New
VC
24
Vivo Capital
California
$14.1M +$13.3M +633,576 New
AG
25
Artal Group
Luxembourg
$12.3M +$11.7M +555,556 New
1
2 3

RYZB Hedge Fund Activity: Q3 2023 in Review

68 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in RayzeBio, Inc. Common Stock (RYZB) for Q3 2023, worth a combined $1.2B.

Buyers outnumbered sellers: 68 funds opened new RYZB positions and 0 closed out — a net gain of 68 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $139M.

  • 68 institutional investors held RayzeBio, Inc. Common Stock (RYZB) as of Q3 2023, up from 0 in Q2 2023.
  • Funds reported $1.2B of RayzeBio, Inc. Common Stock stock for Q3 2023.
  • 68 funds opened new RayzeBio, Inc. Common Stock positions in Q3 2023 and 0 closed out, a net change of +68 holders.
  • The largest RayzeBio, Inc. Common Stock buyer in Q3 2023 was Viking Global Investors, an estimated $139M added.

Based on aggregated 13F filings for Q3 2023.